Application
18048860 · COMBINATION IMMUNE THERAPY AND CYTOKINE CONTROL THERAPY FOR CANCER TREATMENT
Filed 2022-10-24 · Abandoned The official file ↗ · Art unit 1643 · Examiner Bradley Duffy Typical · CPC C12N 5/0638 · Enlivex Therapeutics RDO Ltd · Pearl Cohen LLP
Office actions
1
first was Non-final rejection
RCEs
0
no appeal
To first action
33.9 mo
to disposition 42.2 mo
Statutes raised
103 112 DP
1 actions read